Rabies is a universally fatal but vaccine-preventable viral zoonotic disease causing an estimated 59,000 human deaths annually, with India accounting for nearly 35
Objectives: To explore stakeholder perceptions and experiences regarding NQAS implementation in UPHCs of Berhampur, Odisha; identify key facilitators and barriers; and propose strategies to strengthen quality improvement initiatives. Methodology: A qualitative study was conducted between April and September 2023 in selected UPHCs of Berhampur, Odisha. Purposive sampling was used to recruit stakeholders with direct experience of NQAS implementation and service utilization. A total of 38 participants were included, comprising healthcare providers (medical officers, nurses, pharmacists and laboratory technicians), quality assessors and programme managers, a state consultant/UNICEF representative, and patients attending various health services. Data were collected through in-depth interviews and focus group discussions using semi-structured guides. Thematic analysis was performed through open, axial and selective coding. Data collection continued until thematic saturation was achieved and reported in narrative style. Results: Six major themes emerged: (1) Infrastructure and Resources, (2) Staff Training and Development, (3) Patient-Centred Care, (4) Stakeholder Awareness, (5) Leadership and Management, and (6) Continuous Quality Improvement. Facilitators included leadership commitment, availability of training opportunities, supportive supervision, and recognition of the importance of quality improvement. Major barriers included inadequate infrastructure, overcrowding, staff shortages, irregular training, limited stakeholder awareness, weak patient engagement, and challenges in documentation and monitoring. Conclusion: Implementation of NQAS in urban primary healthcare facilities is influenced by a complex interplay of organizational, resource-related, and behavioural factors. Strengthening infrastructure, workforce capacity, stakeholder awareness, patient engagement, and continuous quality improvement mechanisms may enhance sustainable implementation of NQAS and contribute to improved quality of care in urban primary health settings.
Benign recurrent intrahepatic cholestasis (BRIC) is a rare hereditary cholestatic disorder characterized by recurrent episodes of intermittent cholestatic jaundice and pruritus without causing detectable lasting liver damage. Owing to its rarity and the absence of pathognomonic findings, the diagnosis is often delayed and requires exclusion of more common causes of recurrent cholestasis. We report the case of a 25-year-old male who presented with recurrent episodes of severe cholestatic jaundice with intense generalized pruritus. The patient clinically and biochemically recovered after treatment with ursodeoxycholic acid (UDCA). Based on the characteristic recurrence pattern, severe pruritus, normal serum gamma-glutamyl transferase (GGT) levels during the current episode, normal hepatobiliary imaging, complete clinical recovery between attacks, and exclusion of alternative causes of cholestasis, a presumptive clinical diagnosis of BRIC was made. Although genetic confirmation was not done, the clinical features were most consistent with BRIC.